Ampersand Capital Partners acquires CurTec Group B.V., enhancing strategic growth and innovation in the life sciences supply chain sector.
Information on the Target
CurTec Group B.V. is a leading manufacturer based in Rijen, Netherlands, specializing in high-performance plastic packaging solutions tailored for pharmaceutical and specialty chemical applications. The company operates manufacturing facilities in both the Netherlands and the United States and has a wide-ranging sales network across Europe, North America, and Asia. CurTec is recognized for its dedication to quality, having designed and produced GMP-compliant and UN-certified packaging solutions that ensure secure storage and transport of active pharmaceutical ingredients (APIs), excipients, and other high-value ingredients used in regulated environments.
CurTec's commitment to adherence to cleanliness, compliance, and durability standards makes it a trusted partner for over 300 companies globally, including many prominent pharmaceutical firms. Recent expansions, such as a cutting-edge facility in Westminster, South Carolina, reflect the company’s strategy to better serve the rapidly growing North American market while reinforcing its presence in its European base.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The life sciences industry in the Netherlands is characterized by a robust investment climate and a strong focus on innovation. The country is home to numerous leading research and development institutions
Similar Deals
Torqx Capital Partners → BeterBed
2023
Ampersand Capital Partners
invested in
CurTec Group B.V.
in 2025
in a Other Private Equity deal